Retatrutide is an investigational research compound that is not FDA approved
Western blot analysis Western blot analysis was performed according to the standard procedure to analyze the expression of FTH1 (1:1000, BOSTER, California, USA, #BM4487), NCOA4 (1:1000, Abcam, Cambridge, MA, USA, #ab86707), ATG5 (1:1000, BOSTER, #BA3525-2), -actin (1:2000, Abcam, #ab8226), TP53 (1:1000, BOSTER, #BM4309), CD63 (1:1000, Abcam, #ab193349), CD9 (1:1000, Abcam, #ab92726), and GAPDH (1:1000, Shanghai Siding Biotechnology Co., Ltd., China, #SD0033)
Glutathione was increased about four-fold in catalase-deficient cat2 mutants (mainly as GSSG), but most of this increase was accounted for by changes in chloroplast and vacuolar glutathione, with the cytosolic and nuclear glutathione pools remaining relatively stable (Queval et al., 2011)
It is crucial to validate this data through both in vitro and in vivo investigations
J.SharmaA.LeeH
Any medication changes should be discussed with your prescribing physician